As we famous in our First analysis on X: “Peptide Sciences made 1 / 4 billion and walked absent at the very best. Why combat the FDA in court for ten years after you can just close the notebook and retire? Smartest exit in The grey market.”It's not the end of peptide entry. The February 2026 reclassification restored compounding rights for … Read More